| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -65,857 | -44,085 |
| Depreciation and amortization | 1,123 | 773 |
| Share-based compensation | 8,145 | 5,759 |
| Loss on disposal of assets | -31 | -34 |
| Non-cash interest expense | 164 | 146 |
| Amortization of right-of-use assets | 952 | 628 |
| Loss (gain) on changes in other fair value adjustments | -2,418 | -2,415 |
| (gain) loss from equity method investment | 86 | 677 |
| Amortization of discount on note receivable | 682 | 451 |
| Loss (gain) on change in fair value of warrant liability | -1,230 | -51 |
| Prepaid expenses | -584 | 1,009 |
| Marketable securities | -464 | -464 |
| Convertible note receivable | 0 | - |
| Accounts receivable | -225 | -229 |
| Contract asset | -1,469 | -1,469 |
| Other assets and other current assets | 151 | 45 |
| Accounts payable | 313 | 93 |
| Other liabilities and other current liabilities | -3,913 | -4,441 |
| Deferred revenue | -52 | -43 |
| Lease liabilities | -970 | -633 |
| Net cash used in operating activities | -54,593 | -39,323 |
| Purchases of property, equipment and software | 66 | 66 |
| Purchases of intangible assets | 265 | 265 |
| Proceeds from sale of equipment | 22 | 5 |
| Net cash used in investing activities | -309 | -326 |
| Proceeds from employee stock purchase plan | 218 | 140 |
| Proceeds from issuance of common stock and warrants through underwritten offering, net of issuance cost | 0 | 0 |
| Proceeds from issuance of common stock through atm facility, net of issuance cost | 16,397 | 14,816 |
| Proceeds from issuance of common stock to collaboration partners and licensees | 1,031 | 1,031 |
| Repayment of revolving credit facility | 0 | - |
| Borrowings from term loan debt facility, net of issuance costs paid to lender | 0 | - |
| Net cash provided by financing activities | 17,646 | 15,987 |
| Net (decrease) increase in cash and cash equivalents | -37,256 | -23,662 |
| Cash and cash equivalents at beginning of period | 108,468 | - |
| Cash and cash equivalents at end of period | 71,212 | - |
PRECISION BIOSCIENCES INC (DTIL)
PRECISION BIOSCIENCES INC (DTIL)